This report studies Warfarin Drugs market.
The global Warfarin market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Warfarin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Warfarin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Warfarin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Warfarin include Qilu Pharma, Sine Pharma (Shanghai Pharma), Beijing Jialin Pharmaceutical, Henan Zhongjie Pharma, Shanghai Xudong Haipu Pharmaceutical (SunRise), Amneal Pharma, TEVA (Barr, PLIVA), Cipla (InvaGen) and Orion Corporation Orion Pharma, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Warfarin, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Warfarin, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Warfarin, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Warfarin sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Warfarin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Warfarin sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Beijing Jialin Pharmaceutical
Henan Zhongjie Pharma
Shanghai Xudong Haipu Pharmaceutical (SunRise)
Amneal Pharma
TEVA (Barr, PLIVA)
Cipla (InvaGen)
Orion Corporation Orion Pharma
BRISTOL MYERS SQUIBB
UPSHER SMITH LABS (Sawai Pharmaceutical Co.,Ltd)
Zydus Pharmaceuticals (USA) Inc
Taro Pharmaceutical Industries Ltd.
IPCA LABS LTD
Segment by Type
1mg/Tablet
2.5mg/Tablet
3mg/Tablet
5mg/Tablet
Others
Segment by Application
Mechanical Heart Valves (MHV) Replacement
Atrial Fibrillation (AF)
Deep Vein Thrombosis (DVT)
Pulmonary Embolism (PE)
Others
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Warfarin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Warfarin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Warfarin sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Warfarin Product Introduction
1.2 Market by Type
1.2.1 Global Warfarin Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 1mg/Tablet
1.2.3 2.5mg/Tablet
1.2.4 3mg/Tablet
1.2.5 5mg/Tablet
1.2.6 Others
1.3 Market by Application
1.3.1 Global Warfarin Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Mechanical Heart Valves (MHV) Replacement
1.3.3 Atrial Fibrillation (AF)
1.3.4 Deep Vein Thrombosis (DVT)
1.3.5 Pulmonary Embolism (PE)
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Warfarin Sales Estimates and Forecasts 2019-2030
2.2 Global Warfarin Revenue by Region
2.2.1 Global Warfarin Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Warfarin Revenue by Region (2019-2024)
2.2.3 Global Warfarin Revenue by Region (2025-2030)
2.2.4 Global Warfarin Revenue Market Share by Region (2019-2030)
2.3 Global Warfarin Sales Estimates and Forecasts 2019-2030
2.4 Global Warfarin Sales by Region
2.4.1 Global Warfarin Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Warfarin Sales by Region (2019-2024)
2.4.3 Global Warfarin Sales by Region (2025-2030)
2.4.4 Global Warfarin Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Warfarin Sales by Manufacturers
3.1.1 Global Warfarin Sales by Manufacturers (2019-2024)
3.1.2 Global Warfarin Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Warfarin in 2023
3.2 Global Warfarin Revenue by Manufacturers
3.2.1 Global Warfarin Revenue by Manufacturers (2019-2024)
3.2.2 Global Warfarin Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Warfarin Revenue in 2023
3.3 Global Key Players of Warfarin, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Warfarin Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Warfarin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Warfarin, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Warfarin, Product Offered and Application
3.8 Global Key Manufacturers of Warfarin, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Warfarin Sales by Type
4.1.1 Global Warfarin Historical Sales by Type (2019-2024)
4.1.2 Global Warfarin Forecasted Sales by Type (2025-2030)
4.1.3 Global Warfarin Sales Market Share by Type (2019-2030)
4.2 Global Warfarin Revenue by Type
4.2.1 Global Warfarin Historical Revenue by Type (2019-2024)
4.2.2 Global Warfarin Forecasted Revenue by Type (2025-2030)
4.2.3 Global Warfarin Revenue Market Share by Type (2019-2030)
4.3 Global Warfarin Price by Type
4.3.1 Global Warfarin Price by Type (2019-2024)
4.3.2 Global Warfarin Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Warfarin Sales by Application
5.1.1 Global Warfarin Historical Sales by Application (2019-2024)
5.1.2 Global Warfarin Forecasted Sales by Application (2025-2030)
5.1.3 Global Warfarin Sales Market Share by Application (2019-2030)
5.2 Global Warfarin Revenue by Application
5.2.1 Global Warfarin Historical Revenue by Application (2019-2024)
5.2.2 Global Warfarin Forecasted Revenue by Application (2025-2030)
5.2.3 Global Warfarin Revenue Market Share by Application (2019-2030)
5.3 Global Warfarin Price by Application
5.3.1 Global Warfarin Price by Application (2019-2024)
5.3.2 Global Warfarin Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Warfarin Market Size by Type
6.1.1 US & Canada Warfarin Sales by Type (2019-2030)
6.1.2 US & Canada Warfarin Revenue by Type (2019-2030)
6.2 US & Canada Warfarin Market Size by Application
6.2.1 US & Canada Warfarin Sales by Application (2019-2030)
6.2.2 US & Canada Warfarin Revenue by Application (2019-2030)
6.3 US & Canada Warfarin Market Size by Country
6.3.1 US & Canada Warfarin Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Warfarin Sales by Country (2019-2030)
6.3.3 US & Canada Warfarin Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Warfarin Market Size by Type
7.1.1 Europe Warfarin Sales by Type (2019-2030)
7.1.2 Europe Warfarin Revenue by Type (2019-2030)
7.2 Europe Warfarin Market Size by Application
7.2.1 Europe Warfarin Sales by Application (2019-2030)
7.2.2 Europe Warfarin Revenue by Application (2019-2030)
7.3 Europe Warfarin Market Size by Country
7.3.1 Europe Warfarin Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Warfarin Sales by Country (2019-2030)
7.3.3 Europe Warfarin Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Warfarin Market Size
8.1.1 China Warfarin Sales (2019-2030)
8.1.2 China Warfarin Revenue (2019-2030)
8.2 China Warfarin Market Size by Application
8.2.1 China Warfarin Sales by Application (2019-2030)
8.2.2 China Warfarin Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Warfarin Market Size by Type
9.1.1 Asia Warfarin Sales by Type (2019-2030)
9.1.2 Asia Warfarin Revenue by Type (2019-2030)
9.2 Asia Warfarin Market Size by Application
9.2.1 Asia Warfarin Sales by Application (2019-2030)
9.2.2 Asia Warfarin Revenue by Application (2019-2030)
9.3 Asia Warfarin Sales by Region
9.3.1 Asia Warfarin Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Warfarin Revenue by Region (2019-2030)
9.3.3 Asia Warfarin Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Warfarin Market Size by Type
10.1.1 Middle East, Africa and Latin America Warfarin Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Warfarin Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Warfarin Market Size by Application
10.2.1 Middle East, Africa and Latin America Warfarin Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Warfarin Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Warfarin Sales by Country
10.3.1 Middle East, Africa and Latin America Warfarin Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Warfarin Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Warfarin Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Qilu Pharma
11.1.1 Qilu Pharma Company Information
11.1.2 Qilu Pharma Overview
11.1.3 Qilu Pharma Warfarin Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Qilu Pharma Warfarin Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Qilu Pharma Recent Developments
11.2 Sine Pharma (Shanghai Pharma)
11.2.1 Sine Pharma (Shanghai Pharma) Company Information
11.2.2 Sine Pharma (Shanghai Pharma) Overview
11.2.3 Sine Pharma (Shanghai Pharma) Warfarin Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Sine Pharma (Shanghai Pharma) Warfarin Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sine Pharma (Shanghai Pharma) Recent Developments
11.3 Beijing Jialin Pharmaceutical
11.3.1 Beijing Jialin Pharmaceutical Company Information
11.3.2 Beijing Jialin Pharmaceutical Overview
11.3.3 Beijing Jialin Pharmaceutical Warfarin Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Beijing Jialin Pharmaceutical Warfarin Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Beijing Jialin Pharmaceutical Recent Developments
11.4 Henan Zhongjie Pharma
11.4.1 Henan Zhongjie Pharma Company Information
11.4.2 Henan Zhongjie Pharma Overview
11.4.3 Henan Zhongjie Pharma Warfarin Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Henan Zhongjie Pharma Warfarin Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Henan Zhongjie Pharma Recent Developments
11.5 Shanghai Xudong Haipu Pharmaceutical (SunRise)
11.5.1 Shanghai Xudong Haipu Pharmaceutical (SunRise) Company Information
11.5.2 Shanghai Xudong Haipu Pharmaceutical (SunRise) Overview
11.5.3 Shanghai Xudong Haipu Pharmaceutical (SunRise) Warfarin Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Shanghai Xudong Haipu Pharmaceutical (SunRise) Warfarin Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Shanghai Xudong Haipu Pharmaceutical (SunRise) Recent Developments
11.6 Amneal Pharma
11.6.1 Amneal Pharma Company Information
11.6.2 Amneal Pharma Overview
11.6.3 Amneal Pharma Warfarin Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Amneal Pharma Warfarin Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Amneal Pharma Recent Developments
11.7 TEVA (Barr, PLIVA)
11.7.1 TEVA (Barr, PLIVA) Company Information
11.7.2 TEVA (Barr, PLIVA) Overview
11.7.3 TEVA (Barr, PLIVA) Warfarin Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 TEVA (Barr, PLIVA) Warfarin Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 TEVA (Barr, PLIVA) Recent Developments
11.8 Cipla (InvaGen)
11.8.1 Cipla (InvaGen) Company Information
11.8.2 Cipla (InvaGen) Overview
11.8.3 Cipla (InvaGen) Warfarin Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Cipla (InvaGen) Warfarin Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Cipla (InvaGen) Recent Developments
11.9 Orion Corporation Orion Pharma
11.9.1 Orion Corporation Orion Pharma Company Information
11.9.2 Orion Corporation Orion Pharma Overview
11.9.3 Orion Corporation Orion Pharma Warfarin Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Orion Corporation Orion Pharma Warfarin Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Orion Corporation Orion Pharma Recent Developments
11.10 BRISTOL MYERS SQUIBB
11.10.1 BRISTOL MYERS SQUIBB Company Information
11.10.2 BRISTOL MYERS SQUIBB Overview
11.10.3 BRISTOL MYERS SQUIBB Warfarin Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 BRISTOL MYERS SQUIBB Warfarin Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 BRISTOL MYERS SQUIBB Recent Developments
11.11 UPSHER SMITH LABS (Sawai Pharmaceutical Co.,Ltd)
11.11.1 UPSHER SMITH LABS (Sawai Pharmaceutical Co.,Ltd) Company Information
11.11.2 UPSHER SMITH LABS (Sawai Pharmaceutical Co.,Ltd) Overview
11.11.3 UPSHER SMITH LABS (Sawai Pharmaceutical Co.,Ltd) Warfarin Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 UPSHER SMITH LABS (Sawai Pharmaceutical Co.,Ltd) Warfarin Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 UPSHER SMITH LABS (Sawai Pharmaceutical Co.,Ltd) Recent Developments
11.12 Zydus Pharmaceuticals (USA) Inc
11.12.1 Zydus Pharmaceuticals (USA) Inc Company Information
11.12.2 Zydus Pharmaceuticals (USA) Inc Overview
11.12.3 Zydus Pharmaceuticals (USA) Inc Warfarin Sales, Price, Revenue and Gross Margin (2019-2024)
11.12.4 Zydus Pharmaceuticals (USA) Inc Warfarin Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Zydus Pharmaceuticals (USA) Inc Recent Developments
11.13 Taro Pharmaceutical Industries Ltd.
11.13.1 Taro Pharmaceutical Industries Ltd. Company Information
11.13.2 Taro Pharmaceutical Industries Ltd. Overview
11.13.3 Taro Pharmaceutical Industries Ltd. Warfarin Sales, Price, Revenue and Gross Margin (2019-2024)
11.13.4 Taro Pharmaceutical Industries Ltd. Warfarin Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Taro Pharmaceutical Industries Ltd. Recent Developments
11.14 IPCA LABS LTD
11.14.1 IPCA LABS LTD Company Information
11.14.2 IPCA LABS LTD Overview
11.14.3 IPCA LABS LTD Warfarin Sales, Price, Revenue and Gross Margin (2019-2024)
11.14.4 IPCA LABS LTD Warfarin Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 IPCA LABS LTD Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Warfarin Industry Chain Analysis
12.2 Warfarin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Warfarin Production Mode & Process
12.4 Warfarin Sales and Marketing
12.4.1 Warfarin Sales Channels
12.4.2 Warfarin Distributors
12.5 Warfarin Customers
13 Market Dynamics
13.1 Warfarin Industry Trends
13.2 Warfarin Market Drivers
13.3 Warfarin Market Challenges
13.4 Warfarin Market Restraints
14 Key Findings in The Global Warfarin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Qilu Pharma
Sine Pharma (Shanghai Pharma)
Beijing Jialin Pharmaceutical
Henan Zhongjie Pharma
Shanghai Xudong Haipu Pharmaceutical (SunRise)
Amneal Pharma
TEVA (Barr, PLIVA)
Cipla (InvaGen)
Orion Corporation Orion Pharma
BRISTOL MYERS SQUIBB
UPSHER SMITH LABS (Sawai Pharmaceutical Co.,Ltd)
Zydus Pharmaceuticals (USA) Inc
Taro Pharmaceutical Industries Ltd.
IPCA LABS LTD
听
听
*If Applicable.